Global Advanced Drug Delivery Market Research Report 2023

Publication ID:

PB503233183

Publication Date:

March 14, 2023

Pages:

104

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

Advanced Drug Delivery refers to the formulations, systems and technologies for transporting a pharmaceutical compound in the body as it is needed to safely achieve its desired therapeutic effects. Drug delivery systems (DDS), are based on approaches that are interdisciplinary and that combine pharmaceutics, bio conjugate chemistry, and molecular biology.
Highlights
The global Advanced Drug Delivery market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The Global Advanced Drug Delivery Market is poised to grow at a CAGR of around 7.8% over the next decade to reach approximately $340 billion by 2025. Some of the prominent trends that the market is witnessing include growing focus on unmet medical requirements, increasing demand for generic drugs and biosimilars, rising familiarities of chronic diseases and recent technological developments of advanced drug delivery.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Advanced Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Advanced Drug Delivery.
The Advanced Drug Delivery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Advanced Drug Delivery market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Advanced Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Merck & Co
Antares Pharma
F. Hoffmann-La Roche
Novartis
Bayer
Sanofi
Glaxosmithkline
3M
Pfizer
Johnson & Johnson
Abbott Laboratories
Allergan
Baxter International
Mylan Pharmaceutical
Roche Holding
Segment by Type
Polymeric Drug Delivery
Implants & IUD's
Sustained Release
Targeted Drug Delivery
Prodrugs
Segment by Application
Hospitals
Diagnostic Centers
Ambulatory Surgical Centers/Clinics
Home Care Settings
Other End Users
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Advanced Drug Delivery companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Advanced Drug Delivery Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Polymeric Drug Delivery
1.2.3 Implants & IUD's
1.2.4 Sustained Release
1.2.5 Targeted Drug Delivery
1.2.6 Prodrugs
1.3 Market by Application
1.3.1 Global Advanced Drug Delivery Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Diagnostic Centers
1.3.4 Ambulatory Surgical Centers/Clinics
1.3.5 Home Care Settings
1.3.6 Other End Users
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Advanced Drug Delivery Market Perspective (2018-2029)
2.2 Advanced Drug Delivery Growth Trends by Region
2.2.1 Global Advanced Drug Delivery Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Advanced Drug Delivery Historic Market Size by Region (2018-2023)
2.2.3 Advanced Drug Delivery Forecasted Market Size by Region (2024-2029)
2.3 Advanced Drug Delivery Market Dynamics
2.3.1 Advanced Drug Delivery Industry Trends
2.3.2 Advanced Drug Delivery Market Drivers
2.3.3 Advanced Drug Delivery Market Challenges
2.3.4 Advanced Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Advanced Drug Delivery Players by Revenue
3.1.1 Global Top Advanced Drug Delivery Players by Revenue (2018-2023)
3.1.2 Global Advanced Drug Delivery Revenue Market Share by Players (2018-2023)
3.2 Global Advanced Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Advanced Drug Delivery Revenue
3.4 Global Advanced Drug Delivery Market Concentration Ratio
3.4.1 Global Advanced Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Advanced Drug Delivery Revenue in 2022
3.5 Advanced Drug Delivery Key Players Head office and Area Served
3.6 Key Players Advanced Drug Delivery Product Solution and Service
3.7 Date of Enter into Advanced Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Advanced Drug Delivery Breakdown Data by Type
4.1 Global Advanced Drug Delivery Historic Market Size by Type (2018-2023)
4.2 Global Advanced Drug Delivery Forecasted Market Size by Type (2024-2029)
5 Advanced Drug Delivery Breakdown Data by Application
5.1 Global Advanced Drug Delivery Historic Market Size by Application (2018-2023)
5.2 Global Advanced Drug Delivery Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Advanced Drug Delivery Market Size (2018-2029)
6.2 North America Advanced Drug Delivery Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Advanced Drug Delivery Market Size by Country (2018-2023)
6.4 North America Advanced Drug Delivery Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Advanced Drug Delivery Market Size (2018-2029)
7.2 Europe Advanced Drug Delivery Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Advanced Drug Delivery Market Size by Country (2018-2023)
7.4 Europe Advanced Drug Delivery Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Advanced Drug Delivery Market Size (2018-2029)
8.2 Asia-Pacific Advanced Drug Delivery Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Advanced Drug Delivery Market Size by Region (2018-2023)
8.4 Asia-Pacific Advanced Drug Delivery Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Advanced Drug Delivery Market Size (2018-2029)
9.2 Latin America Advanced Drug Delivery Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Advanced Drug Delivery Market Size by Country (2018-2023)
9.4 Latin America Advanced Drug Delivery Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Advanced Drug Delivery Market Size (2018-2029)
10.2 Middle East & Africa Advanced Drug Delivery Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Advanced Drug Delivery Market Size by Country (2018-2023)
10.4 Middle East & Africa Advanced Drug Delivery Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck & Co
11.1.1 Merck & Co Company Detail
11.1.2 Merck & Co Business Overview
11.1.3 Merck & Co Advanced Drug Delivery Introduction
11.1.4 Merck & Co Revenue in Advanced Drug Delivery Business (2018-2023)
11.1.5 Merck & Co Recent Development
11.2 Antares Pharma
11.2.1 Antares Pharma Company Detail
11.2.2 Antares Pharma Business Overview
11.2.3 Antares Pharma Advanced Drug Delivery Introduction
11.2.4 Antares Pharma Revenue in Advanced Drug Delivery Business (2018-2023)
11.2.5 Antares Pharma Recent Development
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Detail
11.3.2 F. Hoffmann-La Roche Business Overview
11.3.3 F. Hoffmann-La Roche Advanced Drug Delivery Introduction
11.3.4 F. Hoffmann-La Roche Revenue in Advanced Drug Delivery Business (2018-2023)
11.3.5 F. Hoffmann-La Roche Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Advanced Drug Delivery Introduction
11.4.4 Novartis Revenue in Advanced Drug Delivery Business (2018-2023)
11.4.5 Novartis Recent Development
11.5 Bayer
11.5.1 Bayer Company Detail
11.5.2 Bayer Business Overview
11.5.3 Bayer Advanced Drug Delivery Introduction
11.5.4 Bayer Revenue in Advanced Drug Delivery Business (2018-2023)
11.5.5 Bayer Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Advanced Drug Delivery Introduction
11.6.4 Sanofi Revenue in Advanced Drug Delivery Business (2018-2023)
11.6.5 Sanofi Recent Development
11.7 Glaxosmithkline
11.7.1 Glaxosmithkline Company Detail
11.7.2 Glaxosmithkline Business Overview
11.7.3 Glaxosmithkline Advanced Drug Delivery Introduction
11.7.4 Glaxosmithkline Revenue in Advanced Drug Delivery Business (2018-2023)
11.7.5 Glaxosmithkline Recent Development
11.8 3M
11.8.1 3M Company Detail
11.8.2 3M Business Overview
11.8.3 3M Advanced Drug Delivery Introduction
11.8.4 3M Revenue in Advanced Drug Delivery Business (2018-2023)
11.8.5 3M Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Advanced Drug Delivery Introduction
11.9.4 Pfizer Revenue in Advanced Drug Delivery Business (2018-2023)
11.9.5 Pfizer Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Detail
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Advanced Drug Delivery Introduction
11.10.4 Johnson & Johnson Revenue in Advanced Drug Delivery Business (2018-2023)
11.10.5 Johnson & Johnson Recent Development
11.11 Abbott Laboratories
11.11.1 Abbott Laboratories Company Detail
11.11.2 Abbott Laboratories Business Overview
11.11.3 Abbott Laboratories Advanced Drug Delivery Introduction
11.11.4 Abbott Laboratories Revenue in Advanced Drug Delivery Business (2018-2023)
11.11.5 Abbott Laboratories Recent Development
11.12 Allergan
11.12.1 Allergan Company Detail
11.12.2 Allergan Business Overview
11.12.3 Allergan Advanced Drug Delivery Introduction
11.12.4 Allergan Revenue in Advanced Drug Delivery Business (2018-2023)
11.12.5 Allergan Recent Development
11.13 Baxter International
11.13.1 Baxter International Company Detail
11.13.2 Baxter International Business Overview
11.13.3 Baxter International Advanced Drug Delivery Introduction
11.13.4 Baxter International Revenue in Advanced Drug Delivery Business (2018-2023)
11.13.5 Baxter International Recent Development
11.14 Mylan Pharmaceutical
11.14.1 Mylan Pharmaceutical Company Detail
11.14.2 Mylan Pharmaceutical Business Overview
11.14.3 Mylan Pharmaceutical Advanced Drug Delivery Introduction
11.14.4 Mylan Pharmaceutical Revenue in Advanced Drug Delivery Business (2018-2023)
11.14.5 Mylan Pharmaceutical Recent Development
11.15 Roche Holding
11.15.1 Roche Holding Company Detail
11.15.2 Roche Holding Business Overview
11.15.3 Roche Holding Advanced Drug Delivery Introduction
11.15.4 Roche Holding Revenue in Advanced Drug Delivery Business (2018-2023)
11.15.5 Roche Holding Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Merck & Co
Antares Pharma
F. Hoffmann-La Roche
Novartis
Bayer
Sanofi
Glaxosmithkline
3M
Pfizer
Johnson & Johnson
Abbott Laboratories
Allergan
Baxter International
Mylan Pharmaceutical
Roche Holding

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂